The FDA urges pharmacies and consumers to check their blood pressure medication after finding a key ingredient was ...

During the eight-week treatment phase, patients received either moxonidine (0.2 or 0.4 mg/day) or the ACE inhibitor ramipril (2.5 or 5 mg/day). Conclusions: Moxonidine and ramipril exhibited ...